Skip to main content
Till KTH:s startsida Till KTH:s startsida

Publications by Jochen Schwenk

Peer reviewed

Articles

[1]
C. Fredolini et al., "Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections," Communications Medicine, vol. 4, no. 1, 2024.
[3]
R. Zenlander et al., "A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma," Scandinavian Journal of Gastroenterology, vol. 58, no. 9, pp. 998-1008, 2023.
[4]
O. FitzGerald, J. M. Schwenk and H. I. P. P. O. C. R. A. T. E. S. Consortium, "Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis," Therapeutic Advances in Musculoskeletal Disease, vol. 15, 2023.
[5]
R. L. Allesøe et al., "Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models," Nature Biotechnology, vol. 41, no. 3, pp. 399-408, 2023.
[6]
M. J. Iglesias et al., "Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism," Nature Communications, vol. 14, no. 1, 2023.
[7]
[8]
A. Mälarstig et al., "Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation," Nature Communications, vol. 14, no. 1, 2023.
[10]
I. B. Kotliar et al., "Itch receptor MRGPRX4 interacts with the receptor activity-modifying proteins," Journal of Biological Chemistry, vol. 299, no. 5, 2023.
[11]
J. Hauser et al., "Microfluidic Device for Patient-Centric Multiplexed Assays with Readout in Centralized Laboratories," Analytical Chemistry, vol. 95, no. 2, pp. 1350-1358, 2023.
[13]
L. Dahl et al., "Multiplexed selectivity screening of anti-GPCR antibodies," Science Advances, vol. 9, no. 18, 2023.
[14]
C. R. Cederroth et al., "Screening for Circulating Inflammatory Proteins Does Not Reveal Plasma Biomarkers of Constant Tinnitus," Journal of the Association for Research in Otolaryngology, vol. 24, no. 6, pp. 593-606, 2023.
[16]
X. Yu et al., "Advances in plasma proteomics : Moving from technology to precision medicine," PROTEOMICS - Clinical Applications, vol. 16, no. 6, 2022.
[17]
[19]
Z. Yang et al., "Genetic Landscape of the ACE2 Coronavirus Receptor," Circulation, vol. 145, no. 18, pp. 1398-1411, 2022.
[21]
X. Yu et al., "Advances in plasma proteomics : Call for papers for an upcoming special issue," PROTEOMICS - Clinical Applications, vol. 15, no. 6, 2021.
[22]
[24]
[25]
M. J. Iglesias et al., "Identification of Endothelial Proteins in Plasma Associated With Cardiovascular Risk Factors," Arteriosclerosis, Thrombosis and Vascular Biology, vol. 41, no. 12, pp. 2990-3004, 2021.
[26]
[29]
R. Bizzotto, J. M. Schwenk and A. Mari, "Processes Underlying Glycemic Deterioration in Type 2 Diabetes : An IMI DIRECT Study," Diabetes Care, vol. 44, no. 2, pp. 511-518, 2021.
[31]
E. W. Deutsch et al., "p Advances and Utility of the Human Plasma Proteome," Journal of Proteome Research, vol. 20, no. 12, pp. 5241-5263, 2021.
[32]
N. Bar et al., "A reference map of potential determinants for the human serum metabolome," Nature, vol. 588, no. 7836, pp. 135-140, 2020.
[34]
Å. Sivertsson et al., "Enhanced Validation of Antibodies Enables the Discovery of Missing Proteins," Journal of Proteome Research, vol. 19, no. 12, pp. 4766-4781, 2020.
[36]
K. Suhre, M. I. McCarthy and J. M. Schwenk, "Genetics meets proteomics : perspectives for large population-based studies," Nature reviews genetics, 2020.
[37]
T. Abdellah et al., "Integration of molecular profiles in a longitudinal wellness profiling cohort," Nature Communications, vol. 11, no. 1, 2020.
[39]
[42]
M.-G. Hong et al., "Profiles of histidine-rich glycoprotein associate with age and risk of all-cause mortality," Life Science Alliance, vol. 3, no. 10, pp. e202000817, 2020.
[50]
V. Ignjatovic et al., "Mass Spectrometry-Based Plasma Proteomics : Considerations from Sample Collection to Achieving Translational Data," Journal of Proteome Research, vol. 18, no. 12, pp. 4085-4097, 2019.
[51]
E. Lorenzen et al., "Multiplexed analysis of the secretin-like GPCR-RAMP interactome," Science Advances, vol. 5, no. 9, 2019.
[52]
G. S. Omenn et al., "Progress on Identifying and Characterizing the Human Proteome : 2019 Metrics from the HUPO Human Proteome Project," Journal of Proteome Research, vol. 18, no. 12, pp. 4098-4107, 2019.
[53]
F. Edfors et al., "Screening a Resource of Recombinant Protein Fragments for Targeted Proteomics," Journal of Proteome Research, vol. 18, no. 7, pp. 2706-2718, 2019.
[56]
K. Drobin et al., "Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci," Inflammatory Bowel Diseases, vol. 25, no. 2, pp. 306-316, 2019.
[57]
M. Uhlén et al., "The human secretome," Science Signaling, vol. 12, no. 609, 2019.
[59]
Z. Chen et al., "Current applications of antibody microarrays," Clinical Proteomics, vol. 15, 2018.
[62]
G. S. Omenn et al., "Progress on Identifying and Characterizing the Human Proteome : 2018 Metrics from the HUPO Human Proteome Project," Journal of Proteome Research, vol. 17, no. 12, pp. 4031-4041, 2018.
[64]
B. Omazic et al., "A Preliminary Report : Radical Surgery and Stem Cell Transplantation for the Treatment of Patients with Pancreatic Cancer," Journal of immunotherapy (1997), vol. 40, no. 4, pp. 132-139, 2017.
[65]
M. Uhlén et al., "A pathology atlas of the human cancer transcriptome," Science, vol. 357, no. 6352, pp. 660-+, 2017.
[66]
P. J. Thul et al., "A subcellular map of the human proteome," Science, vol. 356, no. 6340, 2017.
[67]
[68]
[69]
E. Pin et al., "Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer," Journal of Proteome Research, vol. 16, no. 1, pp. 204-216, 2017.
[70]
H. Idborg et al., "PROTEIN PROFILING IN PLASMA REVEALS MOLECULAR SUBGROUPS IN SYSTEMIC LUPUS ERYTHEMATOSUS," Annals of the Rheumatic Diseases, vol. 76, pp. A52-A52, 2017.
[71]
[72]
X. Zhou et al., "Thiol–ene–epoxy thermoset for low-temperature bonding to biofunctionalized microarray surfaces," Lab on a Chip, vol. 17, no. 21, pp. 3672-3681, 2017.
[74]
A. Zandian et al., "Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy," Journal of Proteome Research, vol. 16, no. 3, pp. 1300-1314, 2017.
[75]
U. Qundos et al., "Affinity proteomics discovers decreased levels of AMFR in plasma from Osteoporosis patients," PROTEOMICS - Clinical Applications, vol. 10, no. 6, pp. 681-690, 2016.
[76]
B. Ayoglu et al., "Anoctamin 2 identified as an autoimmune target in multiple sclerosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 8, pp. 2188-2193, 2016.
[77]
B. Ayoglu, J. M. Schwenk and P. Nilsson, "Antigen arrays for profiling autoantibody repertoires," Bioanalysis, vol. 8, no. 10, pp. 1105-1126, 2016.
[78]
A. Häggmark-Månberg et al., "Autoantibody targets in vaccine-associated narcolepsy," Autoimmunity, vol. 49, no. 6, pp. 421-433, 2016.
[79]
J. Remnestål et al., "CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease," PROTEOMICS - Clinical Applications, vol. 10, no. 12, pp. 1242-1253, 2016.
[81]
M. Mikus et al., "Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury," Liver international, vol. 37, no. 1, pp. 132-140, 2016.
[82]
R. Sjöberg et al., "Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling," New Biotechnology, vol. 33, no. 5, pp. 582-592, 2016.
[83]
C. Fredolini et al., "Immunocapture strategies in translational proteomics," Expert Review of Proteomics, vol. 13, no. 1, pp. 83-98, 2016.
[84]
M.-G. Hong et al., "Multidimensional Normalization to Minimize Plate Effects of Suspension Bead Array Data," Journal of Proteome Research, vol. 15, no. 10, pp. 3473-3480, 2016.
[85]
B. Ayoglu et al., "Multiplexed protein profiling by sequential affinity capture," Proteomics, vol. 16, no. 8, pp. 1251-1256, 2016.
[86]
A. Häggmark, J. M. Schwenk and P. Nilsson, "Neuroproteomic profiling of human body fluids," PROTEOMICS - Clinical Applications, vol. 10, no. 4, pp. 485-502, 2016.
[88]
M. J. Iglesias et al., "An affinity proteomics study for plasma biomarker candidates of cardiovascular disease in venous thromboembolism," Journal of Thrombosis and Haemostasis, vol. 13, pp. 956-956, 2015.
[91]
C. Hamsten et al., "Heat differentiated complement factor profiling," Journal of Proteomics, vol. 126, pp. 155-162, 2015.
[92]
K. Papp et al., "Multiplex measurement of autoantibody levels and complement activation in rheumatoid arthritis," Molecular Immunology, vol. 67, no. 1, pp. 170-170, 2015.
[93]
A. Häggmark et al., "Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis," American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 5, pp. 574-583, 2015.
[94]
M. Uhlén et al., "Tissue-based map of the human proteome," Science, vol. 347, no. 6220, pp. 1260419, 2015.
[95]
M. Bruzelius et al., "Verema - an affinity proteomics study to identify and translate plasma biomarkers for venous thromboembolism," Journal of Thrombosis and Haemostasis, vol. 13, pp. 954-954, 2015.
[96]
S. Byström et al., "Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis," Journal of Proteome Research, vol. 13, no. 11, pp. 4607-4619, 2014.
[97]
J. Bachmann et al., "Affinity Proteomics Reveals Elevated Muscle Proteins in Plasma of Children with Cerebral Malaria," PLoS Pathogens, vol. 10, no. 4, pp. e1004038, 2014.
[98]
B. Ayoglu et al., "Affinity proteomics within rare diseases : a BIO-NMD study for blood biomarkers of muscular dystrophies," EMBO Molecular Medicine, vol. 6, no. 7, pp. 918-936, 2014.
[99]
F. Henjes et al., "Analysis of Autoantibody Profiles in Osteoarthritis Using Comprehensive Protein Array Concepts," Journal of Proteome Research, vol. 13, no. 11, pp. 5218-5229, 2014.
[101]
L. Fagerberg et al., "Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics," Molecular & Cellular Proteomics, vol. 13, no. 2, pp. 397-406, 2014.
[103]
M. Dezfouli et al., "Magnetic bead assisted labeling of antibodies at nanogram scale," Proteomics, vol. 14, no. 1, pp. 14-18, 2014.
[104]
M. Dezfouli et al., "Parallel barcoding of antibodies for DNA-assisted proteomics," Proteomics, vol. 14, no. 21-22, pp. 2432-2436, 2014.
[105]
A. Häggmark et al., "Plasma profiling revelas three proteins associated to amyotrophic lateral sclerosis," Annals of Clinical and Translational Neurology, vol. 1, no. 8, pp. 544-553, 2014.
[106]
A. Danielsson et al., "The Human Pancreas Proteome Defined by Transcriptomics and Antibody-Based Profiling," PLOS ONE, vol. 9, no. 12, pp. e115421, 2014.
[107]
A. Häggmark et al., "Antibody-based profiling of cerebrospinal fluid within multiple sclerosis," Proteomics, vol. 13, no. 15, pp. 2256-2267, 2013.
[108]
B. Ayoglu et al., "Autoantibody profiling in multiple sclerosis using arrays of human protein fragments," Molecular & Cellular Proteomics, vol. 12, no. 9, pp. 2657-2672, 2013.
[109]
L. Fagerberg et al., "Contribution of antibody-based protein profiling to the human chromosome-centric proteome project (C-HPP)," Journal of Proteome Research, vol. 12, no. 6, pp. 2439-2448, 2013.
[110]
K. Drobin, P. Nilsson and J. M. Schwenk, "Highly multiplexed antibody suspension bead arrays for plasma protein profiling," Methods in Molecular Biology, vol. 1023, pp. 137-145, 2013.
[112]
U. Qundos et al., "Profiling post-centrifugation delay of serum and plasma with antibody bead arrays," Journal of Proteomics, vol. 95, no. SI, pp. 46-54, 2013.
[113]
M. Neiman et al., "Selectivity analysis of single binder assays used in plasma protein profiling," Proteomics, vol. 13, no. 23-24, pp. 3406-3410, 2013.
[114]
[115]
K. Colwill et al., "A roadmap to generate renewable protein binders to the human proteome," Nature Methods, vol. 8, no. 7, pp. 551-8, 2011.
[116]
J. M. Schwenk and P. Nilsson, "Antibody suspension bead arrays," Methods in molecular biology (Clifton, N.J.), vol. 723, pp. 29-36, 2011.
[117]
A. Häggmark et al., "Classification of protein profiles from antibody microarrays using heat and detergent treatment.," New Biotechnology, vol. 29, no. 5, pp. 564-570, 2011.
[118]
B. Hjelm et al., "Generation of monospecific antibodies based on affinity capture of polyclonal antibodies," Protein Science, vol. 20, no. 11, pp. 1824-1835, 2011.
[119]
M. Neiman et al., "Plasma Profiling Reveals Human Fibulin-1 as Candidate Marker for Renal Impairment," Journal of Proteome Research, vol. 10, no. 11, pp. 4925-4934, 2011.
[120]
B. Ayoglu et al., "Systematic antibody and antigen-based proteomic profiling with microarrays," EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, vol. 11, no. 2, pp. 219-234, 2011.
[121]
F. Pontén et al., "The Human Protein Atlas as a proteomic resource for biomarker discovery," Journal of Internal Medicine, vol. 270, no. 5, pp. 428-446, 2011.
[122]
R. Sjöberg et al., "Validation of affinity reagents using antigen microarrays," New Biotechnology, vol. 29, no. 5, pp. 555-563, 2011.
[123]
[124]
J. Gantelius et al., "A lateral flow protein microarray for rapid determination of contagious bovine pleuropneumonia status in bovine serum," Journal of Microbiological Methods, vol. 82, no. 1, pp. 11-18, 2010.
[126]
J. M. Schwenk et al., "Comparative protein profiling of serum and plasma using an antibody suspension bead array approach," Proteomics, vol. 10, no. 3, pp. 532-540, 2010.
[127]
J. M. Schwenk et al., "Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays," Molecular & Cellular Proteomics, vol. 9, no. 11, pp. 2497-2507, 2010.
[128]
K. Larsson et al., "Characterization of PrEST-based antibodies towards human Cytokeratin-17," JIM - Journal of Immunological Methods, vol. 342, pp. 20-32, 2009.
[129]
N. LeBlanc et al., "Development of a magnetic bead microarray for simultaneous and simple detection of four pestiviruses," Journal of Virological Methods, vol. 155, pp. 1-9, 2009.
[130]
J. Rockberg, J. M. Schwenk and M. Uhlén, "Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies," Molecular Oncology, vol. 3, no. 3, pp. 238-247, 2009.
[131]
J. Gantelius et al., "Magnetic bead-based detection of autoimmune responses using protein microarrays.," New biotechnology, vol. 26, pp. 269-276, 2009.
[134]
R. Rimini et al., "Validation of serum protein profiles by a dual antibody array approach," , vol. 73, no. 2, pp. 252-266, 2009.
[135]
J. M. Schwenk et al., "Antibody suspension bead arrays within serum proteomics," Journal of Proteome Research, vol. 7, no. 8, pp. 3168-3179, 2008.
[136]
J. M. Schwenk et al., "Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics," Molecular & Cellular Proteomics, vol. 6, no. 1, pp. 125-132, 2007.

Conference papers

[137]
C. A. Rossi et al., "Longitudinal Relationships Between Proteomics and Beta-Cell Dysfunction in Type 2 Diabetes: an IMI Direct Study," in 8th National Congress of Bioengineering, GNB 2023 : Proceedings, 2023.
[138]
J. Hauser et al., "On-Chip Assay for Home-Sampling, Mail-Based Shipping and Centralized Laboratory Readout," in MicroTAS 2021 : 25th International Conference on Miniaturized Systems for Chemistry and Life Sciences, 2021, pp. 807-808.

Chapters in books

[139]
M. J. Iglesias, J. M. Schwenk and J. Odeberg, "Affinity Proteomics Assays for Cardiovascular and Atherosclerotic Disease Biomarkers," in Protein Microarrays for Disease Analysis : Methods and Protocols, : Springer Nature, 2021, pp. 163-179.
[140]
A. Bendes et al., "Bead-Based Assays for Validating Proteomic Profiles in Body Fluids," in Protein Microarrays for Disease Analysis : Methods and Protocols, : Springer Nature, 2021, pp. 65-78.
[141]
R. Sjöberg et al., "High-density antigen microarrays for the assessment of antibody selectivity and off-target binding," in Epitope Mapping Protocols, : Humana Press Inc., 2018, pp. 231-238.
[142]
B. Ayoglu, P. Nilsson and J. M. Schwenk, "Multiplexed antigen bead arrays for the assessment of antibody selectivity and epitope mapping," in Epitope Mapping Protocols, : Humana Press Inc., 2018, pp. 239-248.
[143]
E. Birgersson, J. . M. Schwenk and B. Ayoglu, "Bead-based and multiplexed immunoassays for protein profiling via sequential affinity capture," in Serum/Plasma Proteomics, : Humana Press, 2017, pp. 45-54.
[144]
C. Hellström et al., "High-density serum/plasma reverse phase protein arrays," in Serum/Plasma Proteomics, : Humana Press, 2017, pp. 229-238.
[145]
A. Häggmark-Månberg, P. Nilsson and J. Schwenk, "Neuroproteomic profiling of cerebrospinal fluid (CSF) by multiplexed affinity arrays," in Neuroproteomics : Methods and Protocols, : Humana Press, 2017, pp. 247-254.
[146]
J. M. Schwenk and P. Nilsson, "Assessment of antibody specificity using suspension bead arrays.," in Methods in Molecular Biology, : Springer, 2011, pp. 183-189.

Non-peer reviewed

Articles

[147]
T. D. Michalettou et al., "Dissecting the interplay between ageing, sex and body mass index on a molecular level," European Journal of Human Genetics, vol. 32, pp. 656-657, 2024.
[149]
D. Davtian et al., "Discovery of Type 2 Diabetes genes using an accessible tissue," European Journal of Human Genetics, vol. 31, pp. 429-430, 2023.
[151]
M. Persson et al., "Searching for Novel Autoantibodies with Clinical Relevance in Psychiatric Disorders," Schizophrenia Bulletin, vol. 44, pp. S120-S121, 2018.
[152]
D. Djureinovic et al., "Autoantibody Profiles of Cancer-Testis Genes in Non-Small Cell Lung Cancer," Journal of Thoracic Oncology, vol. 12, no. 11, pp. S2002-S2002, 2017.
[153]
L. Lourido et al., "IDENTIFICATION OF A SERUM PROTEIN BIOMARKER PANEL FOR THE DIAGNOSIS OF KNEE OSTEOARTHRITIS," Osteoarthritis and Cartilage, vol. 24, pp. S23-S23, 2016.
[154]
L. Lourido et al., "DISCOVERY OF POTENTIAL SERUM BIOMARKERS IN OSTEOARTHRITIS USING PROTEIN ARRAYS," Annals of the Rheumatic Diseases, vol. 74, pp. 373-374, 2015.
[155]
L. Lourido et al., "Discovery of Novel Serum Biomarkers for Osteoarthritis Using Affinity Proteomics," Arthritis & Rheumatology, vol. 67, 2015.
[156]
B. Ayoglu et al., "Proteomic profiling of the autoimmunity repertoire in multiple sclerosis," New Biotechnology, vol. 29, pp. S20-S20, 2012.
Latest sync with DiVA:
2024-07-07 02:21:25